Biotech
One Launch. Five Audiences.
How biotech companies can launch a new therapy without overwhelming their audience

Launching a new therapy is one of the biggest moments in a biotech company's journey. Years of research, clinical trials, regulatory work, and countless hours in the lab all lead to a single announcement. The temptation is to package everything into one polished video and hope it resonates with everyone who watches.
The problem is that your audience isn't one audience at all.
Investors, physicians, researchers, patients, and employees are all approaching the launch from completely different perspectives. They're asking different questions and looking for different answers. A video that dives into clinical data may lose patients in the first minute, while one focused entirely on emotion may leave physicians wanting much more. Trying to create one piece that does everything often results in a message that doesn't fully connect with anyone.
A better approach is to think about the launch as a campaign rather than a single deliverable. Start with one clear story that defines what the therapy is, why it matters, and how it can make a difference. From there, that story can be adapted for each audience without losing its core message.
Investors Want Confidence
Investors aren't just evaluating the science. They're evaluating the company behind it.
They want to understand the vision, the market opportunity, the leadership team, and what comes next. While the therapy may be the headline, they're also looking for evidence that the organization can execute over the long term.
A launch video aimed at investors should reinforce that confidence. Executive interviews, glimpses inside the company, manufacturing capabilities, and a clear picture of the roadmap ahead all help tell a story that extends beyond the product itself.
Physicians Want Clinical Relevance
Healthcare providers come to the launch with a different set of priorities. They're focused on patient outcomes, clinical evidence, mechanism of action, and how a new therapy fits into existing standards of care.
This is where thoughtful motion graphics, scientific animation, and carefully designed visuals become incredibly valuable. Rather than overwhelming physicians with data slides or lengthy presentations, video can distill complicated science into something that's both accurate and easy to absorb.
The goal isn't to simplify the science. It's to communicate it clearly.
Researchers Want Scientific Depth
Researchers often want to go much deeper than a traditional marketing video allows.
They're interested in the platform technology, the methodology, the innovation behind the discovery, and where the science is headed next. Instead of forcing all of that detail into one broad audience piece, it can be much more effective to create dedicated content that explores the research on its own terms.
Those videos continue to provide value long after launch, whether they're shown at conferences, shared with collaborators, or used to recruit top scientific talent.
Patients Want Hope and Understanding
Patients rarely connect with charts or molecular pathways.
They connect with people.
They want to understand what this breakthrough could mean for someone like them. They want hope, reassurance, and a clearer picture of how their lives could change.
Some of the most memorable healthcare stories aren't memorable because of the technology. They're memorable because they remind us why the technology exists in the first place.
Employees Want Purpose
Employees are often the forgotten audience during a launch, even though they've invested years helping bring the therapy to market.
A launch is an opportunity to celebrate that work, reinforce the company's mission, and remind everyone how their individual contributions fit into something much larger. Those internal moments create pride, strengthen culture, and turn employees into authentic ambassadors for the organization.
One Production Can Fuel an Entire Campaign
One misconception we hear fairly often is that speaking to multiple audiences requires multiple productions.
Fortunately, that's rarely the case.
With thoughtful planning, one production can generate an entire library of content. Executive interviews can become investor communications. Scientific interviews can support physician education. Patient stories can power social media and the company website. Footage from the lab can strengthen recruiting efforts, while product visuals find new life in conference presentations, sales presentations, and digital campaigns.
The smartest biotech companies don't think in terms of producing one launch video. They think about creating a complete collection of assets that can support marketing, communications, recruiting, and business development for months after launch.
One Story, Told the Right Way
Biotech companies are solving some of the world's most complex problems. Communicating those breakthroughs shouldn't mean asking every audience to process the information in the same way.
The companies that stand out are the ones that understand their audiences and meet them where they are. They tell one consistent story, but they tell it through different lenses.
That's ultimately what makes a launch successful. It's not about saying everything to everyone. It's about helping each audience understand why the breakthrough matters to them.